ESHAP regimen: Difference between revisions

	WikiDoc Resources for ESHAP regimen
Articles
Most recent articles on ESHAP regimen Most cited articles on ESHAP regimen Review articles on ESHAP regimen Articles on ESHAP regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on ESHAP regimen Images of ESHAP regimen Photos of ESHAP regimen Podcasts & MP3s on ESHAP regimen Videos on ESHAP regimen
Evidence Based Medicine
Cochrane Collaboration on ESHAP regimen Bandolier on ESHAP regimen TRIP on ESHAP regimen
Clinical Trials
Ongoing Trials on ESHAP regimen at Clinical Trials.gov Trial results on ESHAP regimen Clinical Trials on ESHAP regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on ESHAP regimen NICE Guidance on ESHAP regimen NHS PRODIGY Guidance FDA on ESHAP regimen CDC on ESHAP regimen
Books
Books on ESHAP regimen
News
ESHAP regimen in the news Be alerted to news on ESHAP regimen News trends on ESHAP regimen
Commentary
Blogs on ESHAP regimen
Definitions
Definitions of ESHAP regimen
Patient Resources / Community
Patient resources on ESHAP regimen Discussion groups on ESHAP regimen Patient Handouts on ESHAP regimen Directions to Hospitals Treating ESHAP regimen Risk calculators and risk factors for ESHAP regimen
Healthcare Provider Resources
Symptoms of ESHAP regimen Causes & Risk Factors for ESHAP regimen Diagnostic studies for ESHAP regimen Treatment of ESHAP regimen
Continuing Medical Education (CME)
CME Programs on ESHAP regimen
International
ESHAP regimen en Espanol ESHAP regimen en Francais
Business
ESHAP regimen in the Marketplace Patents on ESHAP regimen
Experimental / Informatics
List of terms related to ESHAP regimen

VisualWikitext

Revision as of 15:03, 16 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:ESHAP Regimen; Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen

Overview

ESHAP regimen refers to a regimen consisting of etoposide, methylprednisolone (Solumedrol), high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and Non-Hodgkin's lymphoma^[1]^[2] and rituximab added for the treatment of

Regimen

EEtoposide

SMethylprednisolone (Solumedrol)

HHigh-dose

ACytarabine (Ara-c)

PCisplatin (Platinol)

Indications

Relapsed and refractory Hodgkin's and Non-Hodgkin's lymphoma^[1]^[3]

References

↑ ^1.0 ^1.1 Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA; et al. (1994). "ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study". J Clin Oncol. 12 (6): 1169–76. PMID 8201379.
↑ "NCI Thesaurus".
↑ "NCI Thesaurus".

[pmid8201379-1] 1.0 ^1.1 Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA; et al. (1994). "ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study". J Clin Oncol. 12 (6): 1169–76. PMID 8201379.

[2] "NCI Thesaurus".

[3] "NCI Thesaurus".

[1]

[2]

[3]

@@ Line 7: / Line 7: @@
 ==Overview==
-{{PAGENAME}} refers to a regimen consisting of [[etoposide]], [[methylprednisolone|methylprednisolone (Solumedrol)]], high-dose [[cytarabine]] and [[cisplatin]], used to treat relapsed and refractory [[Hodgkin's lymphoma|Hodgkin's]] and [[Non-Hodgkin's lymphoma]]<ref name="pmid8201379">{{cite journal| author=Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA et al.| title=ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. | journal=J Clin Oncol | year= 1994 | volume= 12 | issue= 6 | pages= 1169-76 | pmid=8201379 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8201379 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63377}}</ref>
+{{PAGENAME}} refers to a regimen consisting of [[etoposide]], [[methylprednisolone|methylprednisolone (Solumedrol)]], high-dose [[cytarabine]] and [[cisplatin]], used to treat relapsed and refractory [[Hodgkin's lymphoma|Hodgkin's]] and [[Non-Hodgkin's lymphoma]]<ref name="pmid8201379">{{cite journal| author=Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA et al.| title=ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. | journal=J Clin Oncol | year= 1994 | volume= 12 | issue= 6 | pages= 1169-76 | pmid=8201379 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8201379 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63377}}</ref> and rituximab added for the treatment of
 ==Regimen==